Pathobiology of fungal infections of the central nervous system with special reference to the Indian scenario

Neurology India

Volumn 55, Issue 3, 2007, Pages 198-215

  Shankar, S ^a   Mahadevan, A ^a   Sundaram, C ^b   Sarkar, Chitra ^c   Chacko, Geeta ^d   Lanjewar, D ^e   Santosh, Vani ^a   Yasha, T ^a   Radhakrishnan, V ^f  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e SIR J J GROUP OF HOSPITALS   (India)

^f SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Aspergillosis; Central nervous system; Cryptococcosis; Dimorphic fungi; Mycotic infections; Pathogenesis; Penicilliosis; Pheohyphomycosis; Zygomycosis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGENICITY; ASPERGILLOSIS; CANDIDA; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DRUG ABUSE; DRUG BINDING; FUNGAL METABOLISM; FUNGUS GROWTH; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INDIAN; MENINGITIS; MUCORMYCOSIS; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PATHOLOGY; PENICILLIUM MARNEFFEI; PHAEOHYPHOMYCOSIS; REVIEW;

EID: 35048882393     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.35680     Document Type: Review

References (182)

1. Kahn FW, Hones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986,86:518-23.
2. Delamater ED, Benham RW. Experimental studies with dermatophytes II. Immunity and hypersensitivity produced in laboratory animals. J Invest Dermatol 1939;1:469-88.
3. Friedman L, Derbes VJ. The question of immunity in ringworm infections. Ann NY Acad Sci 1960;89:179-83.
4. Grappel SF, Bishop CT, Blank F. Immunology of dermatophytes and dermatophytosis. Bact Rev 1974;38:222-50.
5. Rippon JW. Medical mycology-The pathogenic fungi and pathogenic actinomycetes. WB Saunders Co: USA; 1982. p. 154-248.
6. Cox RA, Arnold DR. Immunoglobulin E in Coccidiodomycosis. J Immunol 1979;123:194-200.
7. Graybill JR, Mitchell L. Host defense in Cryptococcosis. III. In vivo alteration of the host immunity. Mycopathologia 1979;69:171-8.
8. Chitravel V, Sundararaj T, Subramanian S, Kumaresan M, Kunjithapadam S. Cell mediated immune response in human cases of rhinosporidiosis. Sabouraudia 1981;19:135-42.
9. Sundaram C, Umabala P, Laxmi V, Purohit AK, Prasad VS, Panigrahi M, et al. Pathology of fungal infections of the central nervous system: 17 years experience from South India. Histopathology 2006;49:396-405.
10. Sharma BS, Khosla VK, Kak VK, Banerjee AK, Vasishtha RK, Prasad KS, et al. Intracranial fungal granuloma. Surg Neurol 1997;47:489-97.
11. Mohr JA, Long H, McKown BA, Muchmore HG. In vitro susceptibility of Cryptococcus neoformans to steroids. Sabouradia 1972;10:171-2.
12. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991;13:1163-9.
13. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregror AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: Influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-6.
14. Chakrabarti A, Jatana M, Kumar P, Chatha L, Kaushal A, Padhye A. Isolation of Cryptococcus neoformans var. gattii from Eucalyptus camaldulensis in India. J Clin Microbiol 1977;35:3340-2.
15. Lazera MS, Pires FD, Camillo-Coura L, Nishikawa MM, Beserra CC, Trilles L, et al. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 1996;34:127-31.
16. Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardtke C, Methling K, et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by PCR-fingerprinting and RAPD-A pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999;20:1790-9.
17. Franzot SP, Hamdan JS, Currie BP, Casadevall A. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: Evidence for both Local Genetic differences and Global Population structure. J Clin Microbiol 1997;35:2243-51.
18. Hussain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001;7:375-81.
19. Kappe R, Muller J. Rapid clearance of Candida albicans mannan antigens by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigens. J Clin Microbiol 1991;29:1665-9.
20. Heelan JS, Corpus A, Kessimian N. False positive reactions in latex agglutination test for Cryptococcus neoformans antigen. J Clin Microbiol 1991;29:1260-1.
21. Hamilton AJ, Jeavons L, Hobby P, Hay RJ. A 34 to 38kDa Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Infect Immun 1992;60:143-9.
22. Hamilton AJ, Goodley J. Purification of the 150kDa exoantigen of Cryptococcus neoformans and its recognition by immune sera. J Clin Microbiol 1993;31:335-9.
23. Banerjee U. Progress in diagnosis of opportunistic infections in HIV/ AIDS. Indian J Med Res 2005;121:395-406.
24. st century". Venugopal PV, Venugopal TV, editors. Medical Council of India: New Delhi; 2002. p. 55-67.
25. Fessler RD, Sobel J, Guyot L, Crane R, Vazguez J, Szuba M, et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:137-42.
26. Wright D, Schneider A, Berger JR. Central nervous system opportunistic infections. Neuroimag Clin N Am 1997;7:513-25.
27. Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, et al. Neurological manifestations of HIV disease. J Assoc Physicians India 2001;49:343-8.
28. Shankar SK, Mahadevan A, Satishchandra P, Udaykumar R, Yasha TC, Santosh V, et al. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Medical Res 2005;121:468-88.
29. Pancharoen C, Chindamporn A, Thisyakorn U. Childhood cryptococcosis: An increasing problem in the era of AIDS. J Med Assoc Thai 2001;84:S86-90.
30. Radhakrishnan VV, Mathai A, Shanmugham J, Mathews GJ. The role of hyaluronidase in experimental Cryptococcal infections. Surg Neurol 1982;17:239-44.
31. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-8.
32. Lee SC, Casadevall A, Dickson DW. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in Cryptococcal meningoencephalitis. Am J Pathol 1996;148:1267-74.
33. Khanna N, Chandramuki A, Desai A, Ravi V. Cryptococcal infection of the central nervous system: An analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol 1996;45:376-9.
34. Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry 1985;48:853-8.
35. Leite AG, Vidal JE, Bonasser Filho F, Nogueira RS, Oliveira AC. Cerebral infarction related to cryptococcal meningitis in an HIV-infected patient: Case report and literature review. Braz J Infect Dis 2004;8:175-9.
36. Goel D, Kalita J, Misra UK. Basilar artery occlusion in Cryptococcal meningitis. Neurol India 1999;47:245-6.
37. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, et al. Profile of neurological disorders associated with HIV/AIDS from Bangalore, South India (1986-1996). Indian J Med Res 2000;111:14-23.
38. Aquinas SR, Tarey SD, Ravindran GD, Nagamani D, Ross C. Cryptococcal meningitis in AIDS - need for early diagnosis. J Assoc Physicians India 1996;44:178-80.
39. Kumaraswamy N, Solomon P, Flaningan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003;36:79-85.
40. Vajpayee M, Konswal S, Sethi P, Wig N. Spectrum of opportunistic infections and profiles of CD4 cell counts among AIDS patients in Northern India. Infection 2003;31:336-40.
41. Lanjewar DN, Jain PP, Shetty CR. Profile of central nervous system pathology in patients with AIDS: An autopsy study from India. AIDS 1998;12:309-13.
42. Sharma SK, Kadhiran T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalized HIV-infected patients from North India. BMC Infect Dis 2004;4:52.
43. Satpute MG, Telang NV, Litake GM, Niphadkar KB, Joshi SG. Prevalence of cryptococcal meningitis at a tertiary care hospital in Western India (1996-2005). J Med Microbiol 2006;55:1301-2.
44. Banerjee U, Dutta K, Majumdar T, Gupta K. Cryptococcosis in India: Awakening of a giant? Med Mycol 2001;39:51-67.
45. Madan M, Ranjitham M, Chandrasekharan S, Sudhakar P. Cryptococcal meningitis in immunocompetent individuals. J Assoc Physicians India 1999;47:933-4.
46. Sanchetee P. Cryptococcal meningitis in immunocompetent patients. J Assoc Physicians India 1998;46:617-9.
47. Prasad KN, Agarwal J, Nag VL, Verma AK, Dixit AK, Ayyagari A. Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India 2003;51:364-6.
48. Nadkarni TD, Menon RK, Desai KI, Goel A. A solitary cryptococcal granuloma in an immunocompetent host. Neurol India 2005;53:365-7.
49. Jaiswal SP, Hemwani N, Sharma N, Athale S, Chitnis DS. Prevalence of fungal meningitis among HIV positive and negative subjects in Indore (MP state). Indian J Med Sci 2002;56:325-9.
50. Pandit L, Agarwal A, Shenoy S, Karnath G. Cryptococcal meningitis and pulmonary crytpococcosis in a non-HIV infected patient. Eur J Gen Med 2006;3:80-2.
51. Malhotra P, Chauhan S, Bhatt P, Varma N, Chakrabarti A, Kumari S, et al. Crytpococcal meninigitis in acute lymphoblastic leukemia. J Assoc Physicians India 2004; 52:831-2.
52. Banerjee U, Dutta K, Casadavell A. Serotype distribution of Cryptococcus neoformans in patients in tertiary care center in India. Med Mycol 2004;42:181-6.
53. Kwon-Chung KJ, Bennett JE. Epidemiological differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120:123-30.
54. Banerjee U, Dutta K, Diwedi M, Sethi S. Cryptococcosis due to C neoformans var gattii: A short review and Indian clinical scenario. Nat J Infect Dis 2001;2:32-6.
55. Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000;38:269-79.
56. Singh A, Bairy I, Shivananda PG. Spectrum of opportunistic infections in AIDS. Indian J Med Sci 2003;57:16-21.
57. Lattif AA, Banerjee U, Prasad R, Biswas A, Wig N, Sharma N, et al. Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients. J Clin Microbiol 2004;42:1260-2.
58. Badarinarayanan G, Gowrisankar R, Muthulakshmi K. Esophageal candidiasis in non-immune suppressed patients in a semi-urban town, southern India. Mycopathologia 2000;149:1-4.
59. Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002;42:207-27.
60. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122-8.
61. Goswami R, Dadhwal V, Tejaswi S, Datta K, Paul A, Haricharan RN, et al. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect 2000;41:162-6.
62. Chimelli L, Mahler-Aranjo MB. Fungal infections. Brain Pathol 1997;7:613-27.
63. th ed. Edward Arnold: London; p. 400-46.
64. Nguyen MH, Yu VL. Meningitis caused by Candida species: An emerging problem in neurosurgical patients. Clin Infect Dis 1995;21:323-7.
65. Chiou CC, Wong TT, Lin HH, Hwang B, Tang RB, Wu KG, et al. Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 1994;19:1049-53.
66. Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis 1994;20:33-40.
67. Jafari HS, Saez-Llorens X, Grimprel E, Argyle JC, Olsen KD, McCracken GH Jr. Characteristics of experimental Candida albicans infection of the central nervous system in rabbits. J Infect Dis 1991;164:389-95.
68. rd ed. Williams and Wilkins: Baltimore MD; 1997. p. 845-53.
69. Herent P, Stynen D, Hernando F, Fruit J, Poulain D. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J Clin Microbiol 1992;30:2158-64.
70. st Century". Venugopal PV, Venugopal TV, editors. Medical Council of India: New Delhi; 2002. p. 97-134.
71. Macdonald F, Odds FC. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol 1980;13:423-35.
72. Radhakrishnan VV, Rout SD, Mohan PK. Disseminated intra-cerebral microabscesses: A immunosuppressed study. Indian J Pathol Microbiol 1994;38:171-8.
73. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989;8:413-37.
74. Torre-Cisneros J, Lopez OL, Kusne S, Martinez AJ, Starzl TE, Simmons RL, et al. CNS aspergillosis in organ transplantation: A clinicopathological study. J Neurol Neurosurg Psychiatry 1993; 56:188-93.
75. Walsh TJ, Hier DB, Caplan LR. Fungal infections of the central nervous system: Comparative analysis of risk factors and clinical signs in 57 patients. Neurology 1985;35:1654-7.
76. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147-73.
77. Beal MF, O'Carroll CP, Kleinman GM, Grossman RI. Aspergillosis of the nervous system. Neurology 1982;32:473-9.
78. Beal MF. Cerebral aspergillosis. N Y State J Med 1988;88:620-2.
79. Boes B, Bashir R, Boes C, Hahn F, McConnell JR, McComb R. Central nervous system aspergillosis. Analysis of 26 patients. J Neuroimaging 1994;4:123-9.
80. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clin 1988;6:241-60.
81. Boon AP, Adams DH, Buckels J, McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol 1990;43:114-8.
82. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-17.
83. Warris A, Voss A, Abrahamsen TG, Verweij PE. Contamination of hospital water with Aspergillus fumigatus and other molds. Clin Infect Dis 2002;34:1159-60.
84. Lass-Florl C, Rath P, Niederwieser D, Kofler G, Wurzner R, Krezy A, et al. Aspergillus terreus infections in hematological malignancies: Molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 2000;46:31-5.
85. Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal resistance to Aspergillus. J Infect 2000;41:203-20.
86. Dortzbach RK, Segrest DR. Orbital aspergillosis. Ophthalmic Surg 1983;14:240-4.
87. Hedges TR, Leung LS. Parasellar and orbital apex syndrome caused by aspergillosis. Neurology 1976;26:117-20.
88. Slavin ML. Primary aspergillosis of the orbital apex. Arch Ophthalmol 1991;109:1502-3.
89. Wolter JR. Diagnosis and management of orbital aspergillosis. Ann Ophthalmol 1976;8:17-20.
90. Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response. Ann Intern Med 1977;86:539-43.
91. Surya Prakash Rao G, Mann SB, Talwar P, Arora MM. Primary mycotic infection of paranasal sinuses. Mycopathologia 1984;84:73-6.
92. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50.
93. Deshpande DH, Desai AP, Dastur HM. Aspergillosis of the central nervous system. A clinical and mycopathological study of 9 cases. Neurol India 1975;23:167-75.
94. Kchir N, Bouratbine A, Boubaker S, Jemel H, Haouet S, Chatti S, et al. Cerebral aspergillotic granuloma. Apropos of a case and a review of the literature. Neurochirurgie 1990;36:132-6.
95. Linares G, McGarry PA, Baker RD. Solid solitary aspergillotic granuloma of the brain. Report of a case due to Aspergillus candidus and review of the literature. Neurology 1971;21:177-84.
96. Mohandas S, Ahuja GK, Sood VP, Virmani V. Aspergillosis of the central nervous system. J Neurol Sci 1978;38:229-33.
97. Dismukes WE, Stamm AM, Graybill JR, Craven PC, Stevens DA, Stiller RL, et al. Treatment of systemic mycoses with ketoconazole: Emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med 1983;98:13-20.
98. Fardoun R, Rao NK, Miskeen AK. Cerebral aspergilloma. Review of the literature apropos of a case. Neurochirurgie 1990;36:45-51.
99. Young RF, Gade G, Grinnell V. Surgical treatment for fungal infections in the central nervous system. J Neurosurg 1985;63:371-81.
100. Whelan MA, Stern J, deNapoli RA. The computed tomographic spectrum of intracranial mycosis: Correlation with histopathology. Radiology 1981;141:703-7.
101. rd. Disseminated aspergillosis. Aspergillus endophthalmitis, optic nerve infarction and carotid artery thrombosis. Arch Pathol 1975;99:353-9.
102. Nenoff P, Kellermann S, Horn LC, Keiner S, Bootz F, Schneider S, et al. Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis. Mycoses 2001;44:407-14.
103. Endo T, Tominaga T, Konno H, Yoshimoto T. Fatal subarachnoid hemorrhage, with brainstem and cerebellar infarction, caused by Aspergillus infection after cerebral aneurysm surgery: Case report. Neurosurgery 2002;50:1147-51.
104. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1988. A 27-year-old man with acute myelomonocytic leukemia in remission and repeated intracranial hemorrhages. N Eng J Med 1988;318:427-40.
105. Seres JL, Ono H, Benner EJ. Aspergillosis presenting as spinal cord compression. J Neurosurg 1972;36:221-4.
106. Polatty RC, Cooper KR, Kerkering TM. Spinal cord compression due to an aspergilloma. South Med J 1984;77:645-8.
107. Nakazato I, Kamada Y, Taira T, Iwamasa T. Massive spinal cord necrosis associated with adult T-cell leukaemia caused by Aspergillus. Virchows Arch A Pathol Anat Histopathol 1993;423:397-400.
108. Sheth NK, Varkey B, Wagner DK. Spinal cord Aspergillus invasion - complication of an aspergilloma. Am J Clin Pathol 1985;84:763-9.
109. Wagner DK, Varkey B, Sheth NK, DaMert GJ. Epidural abscess, vertebral destruction and paraplegia caused by extending infection from an aspergilloma. Am J Med 1985;78:518-22.
110. Naim-Ur-Rahman , Jamjoom A, al-Hedaithy SS, Jamjoom ZA, al-Sohaibani MO, Aziz SA. Cranial and intracranial aspergillosis of sinonasal origin. Report of nine cases. Acta Neurochir (Wein) 1996;138:944-50.
111. Santosh V, Yasha TC, Khanna N, Pal L, Swamy HS, Chandramuki A, et al. Fungal infections of the nervous system - a pathological study. Neurol Infect Epidemiol 1996;1:69-79.
112. Kak VK, Banerjee AK, Radotra BD. Cerebral aspergillosis: Distinct immunosuppressed pattern in 62 cases. Neurol India 1989;37:239.
113. Banerjee AK, Singh MS, Kak VK, Talwar P, Rout D. Cerebral aspergillosis: Report of 8 cases. Indian J Path Microbiol 1977;20:91-9.
114. Bahadur S, Kacker KK, D'Souza B, Chopra P. Paranasal fungal aspergillosis. J Laryngol Otol 1983;97:863-7.
115. Hazarika P, Ravikumar V, Nayak RG, Rao PS, Shivananda PG. Rhinocerebral mycosis. Ear Nose Throat J 1984;63:464-8.
116. Murthy JM, Sundaram C, Prasad VS, Purohit AK, Rammurti S, Laxmi V. Sinonasal aspergillosis: A form of central nervous system aspergillosis in south India. Mycoses 2001;44:141-5.
117. Murthy JM, Sundaram C, Prasad VS, Purohit AK, Rammurthi S, Laxmi V. Aspergillosis of the central nervous system - study of 21 cases seen in a University hospital in South India. J Assoc Physicians India 2000;48:677-81.
118. Nadkarni T, Goel A. Aspergilloma of the brain: An overview. J Postgrad Med 2005;51:S37-41.
119. Dubey A, Patwardhan RV, Sampath S, Santosh V, Sastry KV, Nanda A. Intracranial fungal granuloma: Analysis of 40 patients and review of the literature. Surg Neurol 2005;63:254-60.
120. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147-73.
121. Salaki JS, Louria DB, Chmel H. Fungal and yeast infections of the central nervous system. A clinical review. Medicine (Baltimore) 1984;63:108-32.
122. Veress B, Malik OA, el-Tayeb AA, el-Daoud S, Mahgoub ES, el-Hassan AM. Further observations on the primary paranasal Aspergillus granuloma in the Sudan: A morphological study of 46 cases. Am J Trop Med Hyg 1973;22:765-72.
123. Washburn RG, Kennedy DW, Begley MG, Henderson DK, Bennett JE. Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltimore) 1988;67:231-47.
124. Panda NK, Sharma SC, Chakrabarti A, Mann SB. Paranasal sinus mycoses in north India. Mycoses 1998;41:281-6
125. Srinivasan M, Gonzales CA, George C, Cevallos V, Mascarenhas JM, Asokan B, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997;61:965-71.
126. Al-Doory Y, Wagner GE. Aspergillosis. Thomas CC Publisher: Springfield, II; 1985.
127. de Carpentier JP, Ramamurthy L, Denning DW, Taylor PH. An algorithmic approach to Aspergillus sinusitis. J Laryngol Otol 1994;108:314-8.
128. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: A study of 111 cases. Ann Intern Med 1974;80:176-81.
129. Camarata PJ, Dunn DL, Farney AC, Parker RG, Seljeskog EL. Continual intracavitary administration of amphotericin B as an adjunct in the treatment of Aspergillus brain abscess: Case report and review of the literature. Neurosurgery 1992;31:575-9.
130. Nadkarni TD, Desai KI, Mazumdar D, Goel A, Shenoy A. Ischemic complications after surgical resection of intracranial granuloma. J Clin Neurosci 2003;10:500-2
131. Goel A, Nadkarni T, Desai AP. Aspergilloma in the paracavernous region. Two case reports. Neurol Med Chir (Tokyo) 1996;36:733-6.
132. Sundaram C, Goel D, Uppin SG, Seethajayalakshmi, Borgohain R. Intracranial mycotic aneurysm of Aspergillus species - report of two patients with fatal outcome and review of literature. J Clin Neurosci 2007;14:882-6.
133. Radhakrishnan VV, Saraswathy A, Rout D, Mohan PK. Mycotic aneurysms of the intracranial vessels. Indian J Med Res 1994;100:228-31.
134. Sundaram C, Ratnakar KS, Rao RR, Ranganadham P, Gayathri K, Dinakar I. Diffuse fulminant aspergillosis of the central nervous system. J Assoc Physicians India 1989;37:183-5.
135. Sundaram C, Lakshmi V. Pathogenesis and pathology of brain abscess. Indian J Pathol Microbiol 2006;49:317-26.
136. Tendolkar U, Sharma A, Mathur M, Ranadive N, Sachdev M. Epidural mass due to Aspergillus flavus causing spinal cord compression: A case report and brief update. Indian J Med Microbiol 2005;23:200-3.
137. Xess I, Mohanty S, Jain N, Banerjee U. Prevalence of Aspergillus species in clinical samples isolated in an Indian tertiary care hospital. Indian J Med Sci 2004;58:513-9.
138. Gartenberg G, Bottone EJ, Keusch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: Epidemiology, mycology and treatment. N Engl J Med 1978;299:1115-8.
139. Oberle AD, Penn RL. Nosocomial invasive Saksenaea vasiformis infection. Am J Clin Pathol 1983;80:885-8.
140. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
141. Hussain S, Salahuddin N, Ahmad I, Salahuddin I, Jooma R. Rhinocerebral invasive mycosis: Occurrence in immunocompetent individuals. Eur J Radiol 1995;20:151-5.
142. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Immunosuppressed and iron availability. Diabetes 1982;31:1109-14.
143. Lopes JO, de Mello ES, Klock C. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukaemic patient. Mycoses 1995;38:281-4.
144. Chakrabarti A, Das A, Sharma A, Panda N, Das S, Gupta KL, et al. Ten years experience in zygomycosis at a tertiary care centre in India. J Infect 2001;42:261-6.
145. Sundaram C, Murthy JMK, Purohit AK, Mohan Das S. Rhinocerebral zygomyosis: A immunosuppressed study. Neurol India 1998;46:126-9.
146. Sundaram C, Mahadevan A, Laxmi V, Yasha TC, Santosh V, Murthy JM, et al. Cerebral zygomycosis. Mycosis 2005;48:396-407.
147. rd, Stacy D, Rinaldi MG. Invasive infection due to Apophysomyces elegans in immunocompetent hosts. Clin Infect Dis 1993;17:881-4.
148. Kimura M, Smith MB, McGinnis MR. Zygomycosis due to Apophysomyces elegans: Report of 2 cases and review of the literature. Arch Pathol Lab Med 1999;123:386-90.
149. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: A review of 110 cases. Clin Infect Dis 2004;38:206-16.
150. Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 2000;3:354-8.
151. Dixon DM, Polak A, Szaniszlo PJ. Pathogenicity and virulence of wildtype and melanin-deficient Wangiella dermatitidis. J Med Vet Mycol 1987;25:97-106.
152. Feng B, Wang X, Hauser M, Kaufmann S, Jentsch S, Haase G, et al. Molecular cloning and characterization of WdPKS1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella (Exophiala) dermatitidis. Infect Immun 2001;69:1781-94.
153. Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Zundorf J, Lutticken R, Haase G. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst and killing by human neutrophils. Infect Immun 1999;67:94-101.
154. Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 1982;150:1414-21.
155. Jacobson ES. Pathogenic roles for fungal melanins. Clin Microbiol Rev 2000;13:708-17.
156. Butler MJ, Day AW. Fungal melanins: A review. Can J Microbiol 1998;44:1115-36.
157. Hamilton AJ, Gomez BL. Melanins in fungal pathogens. J Med Microbiol 2002;51:189-91.
158. Crichlow DK, Enrile FT, Memon MY. Cerebellar abscess due to Cladosporium trichoides (Bantianum): Case report. Am J Clin Pathol 1973;60:416-21.
159. Middleton FG, Jurgenson PF, Utz JP, Shadomy S, Shadomy HJ. Brain abscess caused by Cladosporium trichoides. Arch Intern Med 1976;136:444-8.
160. Bennett JE, Bonner H, Janning AE, Lopez RI. Chronic meningitis caused by Cladosporium trichoides. Am J Clin Pathol 1973;59:398-407.
161. Salem FA, Kannangara DW, Nachum R. Cerebral chromomycosis. Arch Neurol 1983;40:173-4.
162. th ed, Edward Arnold: London; p. 400-46.
163. Santosh V, Yasha TC, Khanna N, Pal L, Swamy HS, Chandramuki A, et al. Fungal infections of the nervous system: A pathological study. Neurol Infect Epidemiol 1996;1:69-79.
164. Bagchi A, Aikat BK, Barua D. Granulomatous lesion of the brain due to Cladosporium trichoides. J Indian Med Assoc 1962;38:602-4.
165. Dastur HM, Chaukar AP, Rebello MD. Cerebral chromoblastomycosis due to Cladosporium trichoides (Bantianum) I (A review and case report). Neurol India 1966;14:1-5.
166. Sandhyamani S, Bhatia R, Mohapatra LN, Roy S. Cerebral cladosporiosis. Surg Neurol 1981;15:431-4.
167. Sujatha AP, Mhatre HC. Primary chromoblastomycosis of brain: A case report. Indian J Pathol Microbiol 1981;24:61-6.
168. Chandramukhi A, Ramadevi MG, Shankar SK. Cerebral cladosporiosis: A neuropathological and microbiological study. Clin Neurol Neurosurg 1983;85:245-53.
169. Jayakeerthi A, Dias M, Nagarathna S, Anandh B, Mahadevan A, Chandramuki A. Brain abscess due to Cladophialophora bantiana. Indian J Med Microbiol 2004;22:193-5.
170. Santosh V, Khanna N, Shankar SK, Pal L, Das S, Chandramukhi A, et al. Primary mycotic abscess of the brain caused by Fonsecaea pedrosoi. Case report. J Neurosurg 1995;82:128-30.
171. Banerjee TK, Patwari AK, Dutta R, Anand VK, Chabra A. Cladosporium bantianum meningitis in a neonate. Indian J Pediatr 2002;69:721-3.
172. Gupta SK, Manjunath-Prasad KS, Sharma BS, Khosla VK, Kak VK, Minz M, et al. Brain abscess in renal transplant recipients: Report of three cases. Surg Neurol 1997;48:284-7.
173. Vyas MC, Joshi YR, Bhargava N, Joshi KR, Tanwar RK. Cerebral chromoblastomycosis: A rare case report of cerebral abscess and brief review of literature. Indian J Pathol Microbiol 2000;43:81-5.
174. Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol 1985;84:323-7.
175. Chang CC, Liao ST, Huang WS, Liu JD, Shih LS. Disseminated Penicillium marneffei infection in a patient with acquired immunodeficiency syndrome. Formos Med Assoc 1995;94:572-5.
176. Singh PN, Ranjana K, Singh YI, Singh KP, Sharma SS, Kulachandra M, et al. Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: Report of four autochthonous cases. J Clin Microbiol 1999;37:2699-702.
177. Ranjana KH, Priyokumar K, Singh TJ, Gupta CH, Sharmila L, Singh PN, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect 2002;45:268-71.
178. Kwon-Chung KJ, Bennett JE. Medical mycology. Lea and Febiger: Philadelphia; 1992. p. 866.
179. Bauserman SC, Schochet Jr SS. Bacterial, fungal and parasitic diseases of the central nervous system. In: Principles and practice of neuropathology. Nelson JS, Parisi JE, Schochet SS Jr, editors. Chapter 3. Mosby: London; 1993. p. 42-74.
180. Natarajan M, Balakrishnan D, Muthu AK, Arumugham K. Maduramycosis of the brain: Case report. J Neurosurg 1975;42:229-31.
181. Casadevall A, Steenbergen JN, Nosanchuk JD. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi: The Cryptococcus neoformans paradigm. Curr Opin Microbiol 2003;6:332-7.
182. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci USA 2002;99:15675-80.